Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Dutchak PA"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-3 z 3
    Tytuł:
    GATOR1 Mutations Impair PI3 Kinase-Dependent Growth Factor Signaling Regulation of mTORC1.
    Autorzy:
    Muller M; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Université Laval, Quebec City, QC G1J 2G3, Canada.
    Bélanger J; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Université Laval, Quebec City, QC G1J 2G3, Canada.
    Hadj-Aissa I; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Université Laval, Quebec City, QC G1J 2G3, Canada.
    Zhang C; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Université Laval, Quebec City, QC G1J 2G3, Canada.
    Sephton CF; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Université Laval, Quebec City, QC G1J 2G3, Canada.
    Dutchak PA; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Université Laval, Quebec City, QC G1J 2G3, Canada.
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2024 Feb 08; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 08.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Phosphatidylinositol 3-Kinases*/genetics
    Phosphatidylinositol 3-Kinases*/metabolism
    Epilepsy*
    Humans ; Mechanistic Target of Rapamycin Complex 1/genetics ; Mechanistic Target of Rapamycin Complex 1/metabolism ; Signal Transduction ; GTPase-Activating Proteins/metabolism ; Mutation ; Phosphatidylinositol 3-Kinase/metabolism ; Amino Acids/genetics ; Intercellular Signaling Peptides and Proteins/metabolism ; Membrane Transport Proteins/metabolism ; Nitrogen/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
    Autorzy:
    Pelaez MC; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada.
    Desmeules A; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada.
    Gelon PA; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada.
    Glasson B; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada.
    Marcadet L; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada.
    Rodgers A; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada.
    Phaneuf D; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada.
    Pozzi S; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada.
    Dutchak PA; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada.
    Julien JP; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada.
    Sephton CF; Department of Psychiatry and Neuroscience, CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada. .
    Pokaż więcej
    Źródło:
    Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Nov 16; Vol. 11 (1), pp. 182. Date of Electronic Publication: 2023 Nov 16.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Amyotrophic Lateral Sclerosis*/pathology
    Frontotemporal Dementia*/pathology
    Aged ; Animals ; Humans ; Mice ; Disease Progression ; Mice, Transgenic ; Motor Neurons/metabolism ; Mutation ; NF-kappa B/metabolism ; RNA-Binding Protein FUS/genetics ; RNA-Binding Protein FUS/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    A postzygotic de novo NCDN mutation identified in a sporadic FTLD patient results in neurochondrin haploinsufficiency and altered FUS granule dynamics.
    Autorzy:
    Nicolas G; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France.
    Sévigny M; Department of Psychiatry and Neuroscience, Laval University, Quebec City, QC, Canada, 2325, rue de l'Université, G1V 0A6.; CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada, 2601, chemin de la Canardière, G1J 2G3.
    Lecoquierre F; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France.
    Marguet F; Inserm U1245 and CHU Rouen, Department of Pathology, Normandie University, UNIROUEN, F-76000, Rouen, France.
    Deschênes A; Department of Psychiatry and Neuroscience, Laval University, Quebec City, QC, Canada, 2325, rue de l'Université, G1V 0A6.; CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada, 2601, chemin de la Canardière, G1J 2G3.; Department of Biochemistry, Microbiology and Bioinformatics, Laval University, Quebec City, QC, Canada.
    Del Pelaez MC; Department of Psychiatry and Neuroscience, Laval University, Quebec City, QC, Canada, 2325, rue de l'Université, G1V 0A6.; CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada, 2601, chemin de la Canardière, G1J 2G3.
    Feuillette S; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France.
    Audebrand A; Department of Psychiatry and Neuroscience, Laval University, Quebec City, QC, Canada, 2325, rue de l'Université, G1V 0A6.; CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada, 2601, chemin de la Canardière, G1J 2G3.
    Lecourtois M; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France.
    Rousseau S; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France.
    Richard AC; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France.
    Cassinari K; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France.
    Deramecourt V; Lille Neuroscience and Cognition (Inserm UMRS1172) Alzheimer and Tauopathies, Laboratory of Excellence Distalz (Development of Innovative Strategies for a Transdisciplinary Approach to ALZheimer's Disease), University of Lille, CHU Lille, Lille, France.; Department of Neuropathology, University of Lille, CHU Lille, Lille, France.
    Duyckaerts C; INSERM, CNRS U1127, Institut du Cerveau, Sorbonne Université, ICM, Paris, France.; Laboratoire de Neuropathologie R. Escourolle, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France.
    Boland A; CEA, Centre National de Recherche en Génomique Humaine, Université Paris-Saclay, 91057, Evry, France.
    Deleuze JF; CEA, Centre National de Recherche en Génomique Humaine, Université Paris-Saclay, 91057, Evry, France.
    Meyer V; CEA, Centre National de Recherche en Génomique Humaine, Université Paris-Saclay, 91057, Evry, France.
    Clarimon Echavarria J; Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
    Gelpi E; Neurological Tissue Bank of the Biobank-Hospital Clinic-IDIBAPS, Barcelona, Spain.; Division of Neuropathology, Department of Neurology, Medical University of Vienna, Vienna, Austria.
    Akiyama H; Dementia Research Project, Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Setagaya City, Japan.
    Hasegawa M; Dementia Research Project, Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Setagaya City, Japan.
    Kawakami I; Dementia Research Project, Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Setagaya City, Japan.
    Wong TH; Department of Neurology and Alzheimer Center, Erasmus Medical Center, Rotterdam, The Netherlands.
    Van Rooij JGJ; Department of Neurology and Alzheimer Center, Erasmus Medical Center, Rotterdam, The Netherlands.
    Van Swieten JC; Department of Neurology and Alzheimer Center, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
    Campion D; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France.
    Dutchak PA; Department of Psychiatry and Neuroscience, Laval University, Quebec City, QC, Canada, 2325, rue de l'Université, G1V 0A6.; CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada, 2601, chemin de la Canardière, G1J 2G3.
    Wallon D; UNIROUEN, Inserm U1245 and CHU Rouen, Department of Neurology and CNR-MAJ, Normandie University, F-76000, Rouen, France.
    Lavoie-Cardinal F; Department of Psychiatry and Neuroscience, Laval University, Quebec City, QC, Canada, 2325, rue de l'Université, G1V 0A6.; CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada, 2601, chemin de la Canardière, G1J 2G3.; Institut Intelligence et Données, Laval University, Quebec City, QC, Canada.
    Laquerrière A; Inserm U1245 and CHU Rouen, Department of Pathology, Normandie University, UNIROUEN, F-76000, Rouen, France.
    Rovelet-Lecrux A; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France. .
    Sephton CF; Department of Psychiatry and Neuroscience, Laval University, Quebec City, QC, Canada, 2325, rue de l'Université, G1V 0A6. .; CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada, 2601, chemin de la Canardière, G1J 2G3. .
    Pokaż więcej
    Źródło:
    Acta neuropathologica communications [Acta Neuropathol Commun] 2022 Feb 12; Vol. 10 (1), pp. 20. Date of Electronic Publication: 2022 Feb 12.
    Typ publikacji:
    Case Reports; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Brain/*pathology
    Frontotemporal Dementia/*genetics
    Nerve Tissue Proteins/*genetics
    Neurons/*pathology
    RNA-Binding Protein FUS/*metabolism
    Codon, Nonsense ; Female ; Frontotemporal Dementia/pathology ; Haploinsufficiency ; Humans ; Middle Aged
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-3 z 3

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies